Highlights Wai Chun Bio-Technology Limited

Equities

660 KYG9450C1107

Delayed Hong Kong S.E. Other stock markets 01:38:17 17/05/2024 pm IST			5-day change	1st Jan Change
0.135 ^HKD	+4.65%		+10.66%	-6.25%

01/04	Wai Chun Bio-Technology Limited Announces Change of Independent Non-Executive Director	CI
28/03	Wai Chun Bio-Technology Limited Announces Company Secretary Changes	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wai Chun Bio-Technology's Fiscal H1 Attributable Loss Narrows	01/03	MT
Wai Chun Bio-Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023	29/02	CI
Winding-Up Petition Against Wai Chun Bio-Technology Withdrawn	11/12	MT
Wai Chun Bio-Technology Incurs Loss in Fiscal Year 2023	29/23/29	MT
Wai Chun Bio-Technology Limited Reports Earnings Results for the Full Year Ended June 30, 2023	29/23/29	CI
Wai Chun Bio-Technology's H2 2022 Loss Widens	01/23/01	MT
Wai Chun Bio-Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2022	28/23/28	CI
Wai Chun Bio-Technology to Widen Loss during 18 Months Ended June 30	08/22/08	MT
Wai Chun Bio-Technology Limited Provides Earning Guidance for Eighteen Months Ended 30 June 2022	08/22/08	CI
Wai Chun Bio-Technology Limited Reports Earnings Results for the Eighteen Months Ended June 30, 2022	30/22/30	CI
Wai Chun Bio-Technology Limited Reports Earnings Results for the Second Half Year Ended June 30, 2022	30/22/30	CI
Chun Bio-Technology Widens 2021 Loss Amid Drop in Modified Starch Sales; Shares Slide 5%	01/22/01	MT
Wai Chun Bio-Technology Limited Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28	CI
Wai Chun Bio-Tech Forecasts Over $1 Million in Loss in 2021	22/22/22	MT
Wai Chun Bio-Technology Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2021	21/22/21	CI
Wai Chun Bio-Tech Shareholders to Vote Dec. 24 on Issue of Convertible Bonds as Debt Payment to Chairman	10/21/10	MT
Wai Chun Bio Technology : Tech to Issue Nearly $3 Million Convertible Bonds to Chairman as Debt Payment; Shares Jump 8%	25/21/25	MT
Wai Chun Bio-Technology Limited Reports Earnings Results for the Half Year Ended June 30, 2021	31/21/31	CI
Wai Chun Bio-Technology Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2021	19/21/19	CI
Wai Chun Bio Technology : Tech in Talks to Sell Indirect Subsidiary; Shares Jump 3%	05/21/05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Wai Chun Bio-Technology Limited

Equities

660

KYG9450C1107

Highlights

Filters